- Home
- PFD vs CVRX Comparison
PFD vs CVRX Comparison
Compare PFD & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PFD | CVRX |
|---|---|---|
| Founded | N/A | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 152.5M | 171.7M |
| IPO Year | 1996 | 2021 |
Fundamental Metrics
Financial Performance| Metric | PFD | CVRX |
|---|---|---|
| Price | $11.45 | $7.70 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $11.20 |
| AVG Volume (30 Days) | 15.2K | ★ 410.6K |
| Earning Date | 01-01-0001 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 23.02 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $56,651,000.00 |
| Revenue This Year | N/A | $16.78 |
| Revenue Next Year | N/A | $19.73 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 10.45 |
| 52 Week Low | $10.22 | $4.37 |
| 52 Week High | $12.16 | $13.34 |
Technical Indicators
Market Signals| Indicator | PFD | CVRX |
|---|---|---|
| Relative Strength Index (RSI) | 27.52 | 55.97 |
| Support Level | $11.40 | $6.76 |
| Resistance Level | $11.99 | $8.45 |
| Average True Range (ATR) | 0.13 | 0.62 |
| MACD | -0.07 | 0.07 |
| Stochastic Oscillator | 11.20 | 73.49 |
Price Performance
Historical ComparisonAbout PFD Flaherty & Crumrine Preferred and Income Fund Incorporated
Flaherty & Crumrine Prefd Inc Fund Inc is a United States-based diversified, closed-end management investment company. Its investment objective is to provide its common shareholders with high current income consistent with the preservation of capital. The fund invests in a diversified portfolio of preferred securities, which includes traditional preferred stocks eligible for the inter-corporate dividends received a deduction and fully taxable preferred securities.
About CVRX CVRx Inc.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.